Skip to main content

Table 4 Hazard Ratio of CVD occurrence based on different definitions of metabolic syndrome and its components

From: Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?

Metabolic syndrome definitions

Crude HR (95 % CI)

P-Value

Adjusted HRb (95 % CI)

P-Value

 WHO

2.41 (2.05–2.83)

< 0.001

1.92 (1.62–2.26)

< 0.001

 EGIR

2.03 (1.67–2.47)

< 0.001

1.66 (1.37–2.03)

< 0.001

 ATPIII

2.12 (1.84–2.44)

< 0.001

1.87 (1.61–2.16)

< 0.001

 AHA-NHBI

1.98 (1.72–2.28)

< 0.001

1.93 (1.66–2.25)

< 0.001

 IDFa

1.93 (1.67–2.23)

< 0.001

1.65 (1.43–1.91)

< 0.001

 JIS

2.14 (1.86–2.46)

< 0.001

1.80 (1.56–2.08)

< 0.001

Metabolic syndrome components

 Obesity

1.51 (1.31–1.75)

< 0.001

1.44 (1.24–1.67)

< 0.001

 High triglyceride

1.67 (1.43–1.95)

< 0.001

1.60 (1.37–1.87)

< 0.001

 High LDL-C

1.49 (1.28–1.74)

< 0.001

1.30 (1.11–1.52)

< 0.01

 Low HDL-C

1.07 (0.91–1.25)

0.404

1.19 (1.01–1.39)

< 0.05

 Hypertension

2.51 (2.18–2.89)

< 0.001

1.79 (1.53–2.08)

< 0.001

 Glucose intolerance/ Diabetes

2.21 (1.88–2.59)

< 0.001

1.83 (1.56–2.15)

< 0.001

  1. aWaist Circumference ≥ 95 for both sexes
  2. bAdjusted Model for age, sex, smoking status and physical activity